PharmaShots - Insicive News in 3 Shots | Pharma Biotech MedTech DigiHealth

Roche Signs a Worldwide License Agreement with Parvus Therapeutics to Develop and Commercialize Navacim Platform for Autoimmune Diseases
Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program
Pfizer’s Fragmin (dalteparin sodium) Receives FDA’s Approval for Symptomatic Venous Thromboembolism in Pediatric Patients
Thermo Fisher to Acquire Manufacturing Facility from GSK for ~$100M
Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma

Breakthrough Therapy Designation by the US FDA in 2018

Top 20 BioPharma Companies based on 2018 Total Revenue

Pharma

Roche Signs a Worldwide License Agreement with Parvus Therapeutics to Develop and Commercialize Navacim Platform for Autoimmune Diseases

May 17, 2019May 17, 2019Tuba Khan

Shots: Parvus to receive an upfront & milestones exceeding $800M and royalties on sales of products targeting for IBD, ALD & Celiac diseases, [...]

Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program

May 17, 2019May 17, 2019

Thermo Fisher to Acquire Manufacturing Facility from GSK for ~$100M

May 17, 2019May 17, 2019

GSK Expands its License Agreement with Zymework to Develop and Commercialize Bi-Specific Antibodies

May 16, 2019May 16, 2019

Takeda and Frazier Healthcare Collaborate to Launch a Facility Phathom Pharmaceutical for Gastrointestinal Disorders

May 16, 2019May 17, 2019

Biotech

Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma

May 17, 2019May 17, 2019Tuba Khan

Shots: The P-II EMPOWER CSCC-1 study results involve assessing of Libtayo (cemiplimab-rwlc) in patients with LA & metastatic CSCC and will be presented [...]

NeuClone to Initiate P-I Clinical Study of Stelara (ustekinumab, biosimilar) in Australia

May 16, 2019May 17, 2019

Vertex Signs a 4 Years Agreement with Kymera to Discover and Develop Protein Degradation Therapies

May 16, 2019May 17, 2019

REGENXBIO Launches a Manufacturing Facility for Developing Gene Therapies Based on NAV-Technology

May 15, 2019May 17, 2019

$AstraZeneca and Daiichi Report Results of Trastuzumab Deruxtecan (DS-8201) in P-II DESTINY-Breast01 Study for Refractory HER2+ Metastatic Breast Cancer$

AstraZeneca and Daiichi Report Results of Trastuzumab Deruxtecan (DS-8201) in P-II DESTINY-Breast01 Study for Refractory HER2+ Metastatic Breast Cancer

May 8, 2019May 10, 2019

Digital Health

Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD)

April 11, 2019April 24, 2019Tuba Khan

Shots: Cognoa to get exclusive license rights for Stanford’s Google Glass-based autism technology to develop & commercialize digital therapies for children with autism [...]

Astellas Collaborates with Concerto HealthAI on Real-World Evidence (RWE) Initiative for Acute Myeloid Leukemia (AML)

April 11, 2019April 24, 2019

Amazon Launches Alexa’s Health Services for Managing Health and Handling Patients Data

April 5, 2019April 24, 2019

Apple Launches its Watch Series 4 Enabled with ECG App and Irregular Rhythm Notification in Europe and Hong Kong

March 28, 2019April 24, 2019

MedTech

Ethicon Acquires Rights of Takeda’s TachoSil Fibrin Sealant Patch for ~$400M

May 9, 2019May 10, 2019Tuba Khan

Shots: Takeda tosells its TachoSil Fibrin Sealant Patch along with its ~80 employees to Ethicon for ~ 400M. The transaction is expected to [...]

Medtronic Reports Results of MiniMed 640G System in the SMILE Study for Reducing Hypoglycemia in Patients with Type 1 Diabetes

May 9, 2019May 10, 2019

FDA Issues an Alert on Medtronic’s Pacemaker or Cardiac Resynchronization Therapy Pacemaker for its Premature Battery Depletion

May 8, 2019May 10, 2019

Novartis Reports Results of MS Progression Discussion Tool in a Validation Study for Patients with Multiple Sclerosis

May 7, 2019May 10, 2019

M&A

Boston Scientific to Acquire Vertiflex for its Superion Indirect Decompression System

May 10, 2019May 15, 2019Tuba Khan

Shots: Boston acquires Vertiflex, in all-stock transaction. Vertiflex to receive $465M upfront and commercial milestones for 3yrs. with the expected closure of acquisition [...]

Medtronic To Acquire Titan Spine for its Portfolio of Implants and nanoLock Surface Technology

May 10, 2019May 15, 2019

Pfizer to Acquire Therachon for the Expansion of its Rare Disease Portfolio

May 8, 2019May 10, 2019

Lundbeck to Acquire Abide Therapeutics for $400M

May 6, 2019May 8, 2019

Regulatory

Pfizer’s Fragmin (dalteparin sodium) Receives FDA’s Approval for Symptomatic Venous Thromboembolism in Pediatric Patients

May 17, 2019May 17, 2019Tuba Khan

Shots: The approval is based on the single study results assessing Fragmin (dalteparin sodium) in 38 pediatric patients with symptomatic deep vein thrombosis [...]

Roche and AbbVie’s Venclexta (venetoclax) + Gazyva (obinutuzumab) Receive FDA’s Approval for Untreated Chronic Lymphocytic Leukemia

May 16, 2019May 17, 2019

Merck KGaA and Pfizer’s Bavencio (avelumab) + Inlyta (axitinib) Receive FDA’s Approval as 1L Treatment for Advanced Renal Cell Carcinoma

May 15, 2019May 16, 2019

AliveCor’s KardiaMobile 6L Receives FDA’s Clearance as Six-Lead Personal ECG Device

May 14, 2019May 16, 2019

Diagnostics

Progenics Signs an Exclusive Agreement with ROTOP Pharmaka to Develop and Commercialize Imaging Agent 1404 for Prostate Cancer in Europe

May 15, 2019May 17, 2019Tuba Khan

Shots: Progenics to receive royalties on sales of 1404 in EU. ROTOP to get an exclusive license to develop & commercialize 1404 in [...]

Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis

May 14, 2019May 15, 2019

Boston Scientific Reports Results of Emblem S-ICD System in UNTOUCHED Study to Prevent Sudden Cardiac Death

May 13, 2019May 15, 2019

Abbott Reports Results of High Sensitive Troponin-I Blood Test for Risk Assessment of Heart Diseases

April 30, 2019May 2, 2019

Technology

Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders

May 15, 2019May 16, 2019Tuba Khan

Shots: Abbott to provide its neuromodulation technologies including deep brain stimulation (DBS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) therapy. NIH [...]

Celgene Collaborates with Presage to Evaluate Therapies with its CIVO Technology for Multiple Cancers

May 3, 2019May 7, 2019

Roche Spin-Off Nimble Therapeutics to Commercialize its Drug Development Technology

May 1, 2019May 2, 2019

AstraZeneca Collaborates with BenevolentAI to Develop Therapies for Chronic Kidney Disease and Idiopathic Pulmonary Fibrosis

April 30, 2019May 2, 2019

Subscription

Get PharmaShots news alerts delivered to your email

Name

Email*

Weekly Snapshot

PharmaShots Weekly Snapshot (May 06-10, 2019)
PharmaShots Weekly Snapshot (April 29-May 03, 2019)
PharmaShots Weekly Snapshot (April 22-26, 2019)
PharmaShots Weekly Snapshot (April 15-19, 2019)
PharmaShots Weekly Snapshot (April 08-12, 2019)

PharmaShotsFollow

PharmaShots @Pharmashot·

17 May

Roche Signs a Worldwide License Agreement with Parvus Therapeutics to Develop and Commercialize Navacim Platform for Autoimmune Diseases
https://t.co/t9ybfaBUt5

Reply on Twitter 1129387372280291330 Retweet on Twitter 1129387372280291330 Like on Twitter 1129387372280291330 Twitter 1129387372280291330

PharmaShots @Pharmashot·

17 May

Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program
https://t.co/WV2AyQrwgQ

Reply on Twitter 1129371668789415936 Retweet on Twitter 1129371668789415936 Like on Twitter 11293716687894159361 Twitter 1129371668789415936

Retweet on Twitter PharmaShots Retweeted

PharmaShots @Pharmashot·

16 May

NeuClone to Initiate P-I Clinical Study of Stelara (ustekinumab, biosimilar) in Australia
https://t.co/0cyyQpnvgO

Reply on Twitter 1129009538558902274 Retweet on Twitter 11290095385589022741 Like on Twitter 1129009538558902274 Twitter 1129009538558902274

PharmaShots @Pharmashot·

17 May

Pfizer’s Fragmin (dalteparin sodium) Receives FDA’s Approval for Symptomatic Venous Thromboembolism in Pediatric Patients https://t.co/hWfOUAzHVd

Reply on Twitter 1129341579628441601 Retweet on Twitter 11293415796284416012 Like on Twitter 11293415796284416011 Twitter 1129341579628441601

Retweet on Twitter PharmaShots Retweeted

PharmaShots @Pharmashot·

16 May

Takeda and Frazier Healthcare Collaborate to Launch a Facility Phathom Pharmaceutical for Gastrointestinal Disorders https://t.co/km80KgvbLY

Reply on Twitter 1128981543576150016 Retweet on Twitter 11289815435761500161 Like on Twitter 11289815435761500161 Twitter 1128981543576150016

Contact us

Leave a Message

Name *

Email *

Comment or Message *

Phone

Roche Signs a Worldwide License Agreement with Parvus Therapeutics to Develop and Commercialize Navacim Platform for Autoimmune Diseases

﻿Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program

﻿Pfizer’s Fragmin (dalteparin sodium) Receives FDA’s Approval for Symptomatic Venous Thromboembolism in Pediatric Patients

﻿Thermo Fisher to Acquire Manufacturing Facility from GSK for ~$100M

﻿Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma

Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program

Pfizer’s Fragmin (dalteparin sodium) Receives FDA’s Approval for Symptomatic Venous Thromboembolism in Pediatric Patients

Thermo Fisher to Acquire Manufacturing Facility from GSK for ~$100M

Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma